CGMP Dependent Kinase Inhibitor Peptide acetate
CGMP Dependent Kinase Inhibitor Peptide acetate is a highly selective, ATP-competitive inhibitor of cGMP-dependent protein kinase (PKG/cGKI) . cGMP Dependent Kinase Inhibitor Peptide acetate is a synthetically produced peptide with a Ki value of 86 μM. cGMP Dependent Kinase Inhibitor Peptide acetate inhibits PKG-dependent myosin light chain phosphorylation in vascular smooth muscle cells, blocking vasodilatory signaling, and is used in cardiovascular disease research. cGMP Dependent Kinase Inhibitor Peptide acetate also inhibits PfPKG in Plasmodium and Toxoplasma, and is used in antiparasitic research.
Product Specifications
Purity
97.87% (May vary between batches)
Molecular Weight
1003.16
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PO54304M2 100 µg
Influenza A H5N1 (A/Egypt/2321-NAMRU3/2007) Hemagglutinin Protein (HA1 Subunit) (His Tag)
Sign In for Pricing
View Details 
250708-ML750 100 µL
PTPRN2 (Protein Tyrosine Phosphatase, Receptor Type, N Polypeptide 2, IA-2beta, IAR, ICAAR, PTPRP) (MaxLight 750) discontinued
Sign In for Pricing
View Details 